Detalhe da pesquisa
1.
Preoperative Treatment of Locally Advanced Rectal Cancer.
N Engl J Med
; 389(4): 322-334, 2023 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272534
2.
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot.
Cancer
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662502
3.
Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients undergoing curative intent resection.
HPB (Oxford)
; 26(1): 145-153, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37752029
4.
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Oncologist
; 28(10): 917-e966, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339254
5.
Pancreatic involvement due to immune checkpoint inhibitors: a proposed classification.
Cancer Immunol Immunother
; 72(4): 895-901, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36161510
6.
Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis: Results from a Prospective Pilot Study.
Ann Surg Oncol
; 30(1): 395-403, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972667
7.
Anorectal melanoma.
J Surg Oncol
; 128(4): 635-644, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37395165
8.
The role of microbiome in pancreatic cancer.
Cancer Metastasis Rev
; 40(3): 777-789, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34455517
9.
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer.
Ann Surg Oncol
; 29(3): 1579-1591, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724125
10.
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma.
J Natl Compr Canc Netw
; 20(9): 1023-1032.e3, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075389
11.
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer.
Ann Surg
; 273(2): 341-349, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30946090
12.
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study.
Lancet Oncol
; 21(10): 1353-1365, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32919526
13.
Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma.
Oncologist
; 25(11): e1681-e1690, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663355
14.
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Oncologist
; 25(5): 380-e763, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826977
15.
Clinical impact of celiac ganglia metastasis upon pancreatic ductal adenocarcinoma.
Pancreatology
; 20(1): 110-115, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31759906
16.
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
Pancreatology
; 20(1): 101-109, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31787526
17.
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.
Lancet Oncol
; 20(4): 518-530, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30857956
18.
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.
Cancer
; 124(3): 537-545, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29044496
19.
Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.
Genet Med
; 20(1): 119-127, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28726808
20.
An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204).
Oncology
; 94(1): 39-46, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29040974